UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy

Blood, 1993-06, Vol.81 (11), p.3091-3096

1993

Link zum Volltext

Verfügbarkeit prüfen

Clinical Significance of Multidrug Resistance P-Glycoprotein Expression on Acute Nonlymphoblastic Leukemia Cells at Diagnosis

Blood, 1992-01, Vol.79 (2), p.473-476

1992

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia

Blood, 1999-12, Vol.94 (11), p.3694-3701

1999

Link zum Volltext

Verfügbarkeit prüfen

Transplantation with selected autologous peripheral blood CD34 +Thy1 + hematopoietic stem cells (HSCs) in multiple myeloma : Impact of HSC dose on engraftment, safety, and immune reconstitution

Experimental hematology, 2000-07, Vol.28 (7), p.858-870

2000

Link zum Volltext

Verfügbarkeit prüfen

Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature

Journal of clinical oncology, 1993-12, Vol.11 (12), p.2370-2379

1993

Link zum Volltext

Verfügbarkeit prüfen

Rearrangement of CCND1 (BCL1/PRAD1) 3' Untranslated Region in Mantle-Cell Lymphomas and t(11ql3)-Associated Leukemias

Blood, 1994-06, Vol.83 (12), p.3689-3696

1994

Link zum Volltext

Verfügbarkeit prüfen

Daunorubicin enhances intracellular production of hydrogen peroxide by human neutrophils: A flow cytometric study

Biology of the cell, 1992, Vol.76 (2), p.262-262

1992

Link zum Volltext

Verfügbarkeit prüfen

Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial

Journal of clinical oncology, 1995-01, Vol.13 (1), p.11-18

1995

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in angioimmunoblastic lymphadenopathy

Cancer, 1987-01, Vol.59 (2), p.208-212

1987

Link zum Volltext

Verfügbarkeit prüfen

Interdependence between Cytokines and Cell Adhesion Molecules to Induce Interleukin-6 Production by Stromal Cells in Myeloma

Leukemia & lymphoma, 1998-12, Vol.32 (1-2), p.107-119

1998

Link zum Volltext

Verfügbarkeit prüfen

Actualité thérapeutique dans les leucémies aiguës myéloïdes

Hématologie (Montrouge), 1998, Vol.4 (3), p.12-15

ARCHIMBAUD, E

1998

Link zum Volltext

Verfügbarkeit prüfen

Thrombopoietic factors potentially useful in the treatment of acute leukemia

Leukemia research, 1998-12, Vol.22 (12), p.1155-1164

1998

Link zum Volltext

Verfügbarkeit prüfen

Non HLA-Restricted Cytotoxic Cells and Their Modulation in Acute Myelogenous Leukemia

Leukemia & lymphoma, 1992, Vol.6 (6), p.449-457

Archimbaud, Eric

1992

Link zum Volltext

Verfügbarkeit prüfen

CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia

Leukemia, 1995-02, Vol.9 (2), p.249-253

1995

Link zum Volltext

Verfügbarkeit prüfen

Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy

British journal of haematology, 1989-06, Vol.72 (2), p.161-166

1989

Link zum Volltext

Verfügbarkeit prüfen

Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia

Journal of clinical oncology, 1994-02, Vol.12 (2), p.262-267

1994

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Study of Interleukin-2 in 49 Patients with Relapsed or Refractory Acute Leukemia

Leukemia & lymphoma, 1998, Vol.31 (3-4), p.343-349

1998

Link zum Volltext

Verfügbarkeit prüfen

All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial

The hematology journal : the official journal of the European Haematology Association, 2002, Vol.3 (1), p.49

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(78)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(61)
Life Sciences & Biomedicine
(61)
Science & Technology
(61)
Biological And Medical Sciences
(46)
Medical Sciences
(44)
Hematology
(43)
Female
(38)
Middle Aged
(38)
Male
(34)
Adult
(32)
Aged
(29)
Oncology
(29)
Hematologic And Hematopoietic Diseases
(21)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(18)
Pharmacology. Drug Treatments
(17)
Antineoplastic Agents
(15)
Acute Disease
(14)
Adolescent
(14)
Prognosis
(14)
Chemotherapy
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS

Randomized comparison of double induction and timed-sequential induction to a “3 + 7” induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study

High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy

Effect of All Transretinoic Acid in Newly Diagnosed Acute Promyelocytic Leukemia. Results of a Multicenter Randomized Trial

Clinical Significance of Multidrug Resistance P-Glycoprotein Expression on Acute Nonlymphoblastic Leukemia Cells at Diagnosis

A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia

Transplantation with selected autologous peripheral blood CD34 +Thy1 + hematopoietic stem cells (HSCs) in multiple myeloma : Impact of HSC dose on engraftment, safety, and immune reconstitution

All-Transretinoic Acid Followed by Intensive Chemotherapy Gives a High Complete Remission Rate and May Prolong Remissions in Newly Diagnosed Acute Promyelocytic Leukemia: A Pilot Study on 26 Cases

Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature

Rearrangement of CCND1 (BCL1/PRAD1) 3' Untranslated Region in Mantle-Cell Lymphomas and t(11ql3)-Associated Leukemias

Daunorubicin enhances intracellular production of hydrogen peroxide by human neutrophils: A flow cytometric study

Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial

Prognostic factors in angioimmunoblastic lymphadenopathy

Interdependence between Cytokines and Cell Adhesion Molecules to Induce Interleukin-6 Production by Stromal Cells in Myeloma

Actualité thérapeutique dans les leucémies aiguës myéloïdes

Thrombopoietic factors potentially useful in the treatment of acute leukemia

Effectiveness and Pharmacokinetics of Low-Dose All-trans Retinoic Acid (25 mg/m2) in Acute Promyelocytic Leukemia

Non HLA-Restricted Cytotoxic Cells and Their Modulation in Acute Myelogenous Leukemia

CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia

Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy

Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia

A Phase II Study of Interleukin-2 in 49 Patients with Relapsed or Refractory Acute Leukemia

All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial

Suchergebnisse filtern